Combined continuous hormone therapy (HT) vs placebo
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Combined continuous hormone therapy (HT) probably leads to higher coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
- Long‐term hormone therapy for perimenopausal and postmenopausal women 2017 · Cochrane Headline outcomes onlyRR 1.89 [1.15, 3.1]2 studies · 20993 participantsModerate